Trial intelligence / Profile preview

Hormone normalization in obese hypogonadal men

2010-021268-13Phase 2Terminated

Sponsor: University College Dublin
Start: Oct 2010
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 2, randomised, open-label trial of letrozole and testosterone undecanoate in Hypoandrogenism (TD) and obesity (3 arms), sponsored by University College Dublin. Primary endpoint: Change in serum C-reactive protein. Started Oct 2010; status: terminated.

Drugs

letrozoletestosterone undecanoate

Conditions

Hypoandrogenism (TD)obesity

Beyond the preview

Go deeper on 2010-021268-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021268-13.